Skip to main content

Research

The new European Bauhaus a better future together

The new European Bauhaus: a better future together

The New European Bauhaus (NEB) project was initiated to carry the values of the European Green Deal. It is an interdisciplinary approach in which technology, design, art and science combine forces to build a more sustainable, enriching and inclusive future. https://www.youtube.com/watch?v=lsDefOuqkOo In this context, the European Parliament's Panel for the Future of Science and Technology ...

Ampules, syringe, tablets and spray

Could a ‘European Medicines Infrastructure’ help solve market failures in pharmaceutical research and development?

Interview with Massimo Florio (Professor of Public Economics, University of Milan, Italy) about a new European approach to pharmaceutical policy. In response to the Covid-19 crisis, the European Union has increased its commitment to the EU public health agenda. It has strengthened the mandate of both the European Medicines Agency (EMA) and the European Centre ...

Low poly brain illustration isolated on blue BG

Edvard Moser: “Neuroscience is evolving at an accelerated speed”

On 12 October, the Panel for the Future of Science and Technology (STOA), in collaboration with the International Brain Initiative (IBI) and the Kavli Foundation, organised a workshop at the European Parliament entitled "The International Brain Initiative – Shaping the future of globally coordinated neuroscience”. Keynote speaker was Prof Edvard Moser, founding director of the ...

Low poly brain illustration isolated on blue BG

Jan G. Bjaalie on international brain research: “We are now in a critical phase”

“Catalysing and advancing neuroscience research through international collaboration and knowledge sharing. Uniting diverse ambitions to expand scientific possibility. And disseminating discoveries for the benefit of humanity.” With this intention, brain researchers all over the world joined forces and formed the International Brain Initiative in December 2017. One of its leading experts is Jan G. Bjaalie, ...

Coronavirus mutation vector background with disease molecules on blue. Medical research or pandemic virus prevention banner with COVID-19 abstract images under microscope. Europe coronavirus mutation

SARS-CoV-2: the challenges of mutation and possible strategies

The efficacy of the current COVID-19 vaccines might be lower against the new variants of SARS-CoV-2. The new strain that emerged in the United Kingdom has a higher transmissibility than previous strains of the virus. We asked scientists whether the new mutations are a threat to the current public health measures and to COVID-19 vaccines.

Tocilizumab, Coronavirus Covid-19 treatment illustration banner

Tocilizumab : a treatment alternative in COVID-19 pneumonia

Patients with severe COVID-19 pneumonia often need to be mechanically intubated and have an increased mortality risk. Tocilizumab, a drug used against the cytokine storm underlying this clinical condition, has shown positive effects in clinical trials.

The differences between SARS-CoV-1 and SARS-CoV-2

The differences between SARS-CoV-1 and SARS-CoV-2

Although according to the World Health Organization the novel coronavirus is primarily transmitted between people through respiratory droplets and contact routes, some scientists suggest we should also consider the possibility of aerosol transmission. As the pandemic continues to unfold, research and discussions are ongoing to determine how best to tackle it. Two leading experts offer their opinions, alongside an exploration into some of the vital research being conducted.

Covid-19: Boosting antiviral research

Covid-19: Boosting antiviral research

As countries around the world implement national pandemic plans, we take a look at some of the research strategies being pursued to tackle Covid-19.